Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2010 - 2026)

Jazz Pharmaceuticals' Other Working Capital Changes history runs 15 years deep, the most recent figure standing at $529000.0 for Q3 2025.

• On a quarterly basis, Other Working Capital Changes fell 75.52% year-over-year to $529000.0 in Q3 2025; TTM through Sep 2025 was -$9.6 million, a 63.72% increase from a year earlier, with the FY2024 full-year figure at -$14.5 million, down 135.47% from the prior year.
• Other Working Capital Changes fell to $529000.0 in Q3 2025 per JAZZ's latest filing, from $792000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $89.8 million in Q4 2023 and bottomed at -$54.9 million in Q1 2024.
• The 5-year median for Other Working Capital Changes is $516000.0 (2022), against an average of $1.9 million.
• Across the five-year window, Other Working Capital Changes sank 1715.68% in 2021 and jumped 905.34% in 2022, its largest moves.
• Year by year, Other Working Capital Changes stood at -$21.4 million in 2021, then jumped by 54.14% to -$9.8 million in 2022, then slumped by 171.43% to -$26.7 million in 2023, then soared by 44.32% to -$14.9 million in 2024, then jumped by 103.56% to $529000.0 in 2025.
• Per Business Quant, the three latest JAZZ Other Working Capital Changes figures stand at $529000.0 (Q3 2025), $792000.0 (Q2 2025), and $4.0 million (Q1 2025).